(Q69610211)
Statements
Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study (English)
J T Thigpen
J A Blessing
H D Homesley
scientific article published on 01 February 1986